Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
First responders' risk for COVID-19 infection is about 60% more than other essential workers, including healthcare workers (HCWs), according to a study published late last week in JAMA Health Forum.
Three more Ebola cases, one of them fatal, were reported in the Democratic Republic of the Congo's (DRC's) latest resurgence near Beni in North Kivu province, according to a World Health Organization (WHO) DRC office tweet today. The case total is now five including three deaths, said the World Health Organization (WHO) African regional office today on Twitter.
A second Ebola case has been confirmed in the latest outbreak in the Democratic Republic of the Congo (DRC), a city health official from the city of Beni told Reuters.
The World Health Organization (WHO) today released a new tool to help countries calculate the costs of implementing multisectoral national action plans (NAPs) for antimicrobial resistance (AMR).
In the weeks before the boy got sick, 3 of his neighbors—a father and 2 kids—died from a similar illness but weren't tested.
The World Health Organization (WHO) and its partners today called for urgent action to address meningitis, while launching the first ever global strategy to battle the disease, called the Global Roadmap to Defeat Meningitis by 2030.
By 2030, the goals are to eliminate epidemics of bacterial meningitis—the deadliest form of the disease—and to reduce deaths by 70% and halve the number of cases, the WHO said in a press release.
Since March 2020, children's body mass index (BMI) has increased at almost double its prepandemic rate, according to a study today in Morbidity and Mortality Weekly Report (MMWR).
Admission screening for carbapenem-resistant Enterobacterales (CRE) at a Vietnamese children's hospital was associated with reduced CRE acquisition, hospital-acquired infections (HAIs), duration of hospital stay, and costs, according to a study published this week in Antimicrobial Resistance and Infection Control.
Early use of convalescent plasma didn't prevent COVID-19 progression in a group of high-risk adult outpatients, concludes a National Institutes of Health (NIH) study yesterday in the New England Journal of Medicine (NEJM).